跳至主要内容
临床试验/NL-OMON25182
NL-OMON25182招募中不适用

A Randomized Clinical Trial of Surgery Versus Radiosurgery (Stereotactic Radiotherapy) in Patients With Stage IA NSCLC Who Are Fit to Undergo Primary Resection.

VU University Medical Center0 个研究点目标入组 960 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
960

研究概览

简要总结

Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Hurkmans CW, Cuijpers JP, Lagerwaard FJ, Widder J, van der Heide UA, Schuring D, Senan S. Radiat Oncol. 2009 Jan 12;4:1

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with a cytological or histological diagnosis of stage IA non-cell lung cancer diagnosed in accordance with Dutch CBO guidelines [2004]. When no pathological diagnosis is available, a patient with a new or growing pulmonary lesion with radiological features consistent with malignancy AND a lesion showing uptake on a FDG-PET scan will be eligible [Herder 2005];
  • 2. No evidence of regional or distant metastases on a standardized FDG-PET scan within 6 weeks of any protocol treatment;

排除标准

  • 1. Prior chemotherapy or radiotherapy for the present diagnosis of NSCLC;
  • 2. History of any active malignancy (other than NSCLC) unless treated more than 3 years with curative intent and no recurrence, with the exception of non-melanoma skin cancers or in-situ cervical cancers;

研究者

发起方
VU University Medical Center

相似试验